N/A
N=862
Pharmacist Intervention to Decrease Medication Errors in Heart Disease Patients (The PILL-CVD Study)
Acute Coronary Syndrome · Heart Failure
Bottom Line
View on ClinicalTrials.gov: NCT00632021 ↗Enrolled (actual)
862
Serious AEs
0.0%
Results posted
Aug 2017
Primary outcome: Primary: Number of Serious Medication Errors as Determined by Interview and Medical Chart Review — 0.95; 0.87 serious medication errors
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Pharmacist Intervention for Low-Literacy in Cardiovascular Disease (Behavioral)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Vanderbilt University Medical Center
- Primary completion
- Sep 2009
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Serious Medication Errors as Determined by Interview and Medical Chart Review |
0.95; 0.87 | — |
| SECONDARY Number of Participants With Unplanned Hospitalizations and Emergency Department Visits |
66; 61; 362; 362 | — |
Summary
Many people who have recently left the hospital have difficulties managing their medications, and medication errors are common. Patients with low health literacy levels may have a particularly difficult time understanding medication dosing and instructions. This study will evaluate a literacy-focused program that provides educational assistance from pharmacists at the time of hospital discharge to people hospitalized with heart problems.
Eligibility Criteria
Inclusion Criteria
- Admitted to a participating study hospital
- Diagnosis of acute coronary syndromes or heart failure
Exclusion Criteria
- Too ill to participate
- Corrected visual acuity worse than 20/200
- Severe hearing impairment
- Patient is not being discharged to their home
- No regular telephone number
- Not fluent in English or Spanish
- Unintelligible speech
- In police custody
- Caregiver manages all medications
- Delirium or severe dementia
- Psychotic illness
- Already participating in a conflicting study
Data sourced from ClinicalTrials.gov (NCT00632021). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.